60 likes | 176 Vues
This chapter explores the various treatment options available for infertile women, focusing on the use of human menopausal gonadotropin (hMG) or GnRH agonists to induce ovulation, followed by human chorionic gonadotropin (hCG) administration. Seasonal changes in conception ability and IVF cycle outcomes in the U.S. are discussed, alongside the costs associated with assisted reproductive technologies. Advanced fertility treatments are presented, addressing common issues such as ovarian dysfunction, tubal blockages, and uterine problems, with options for donor sperm utilization in specific cases.
E N D
Chapter 16 Infertility
Figure 16-1 Treatment of an infertile woman with human menopausal gonadotropin(hMG) or a GnRH stimulatory agonist followed by human chorionic gonadotropin (hCG) to induce ovulation. The shaded area represents menses
Figure 16-2 Outcome of IVF cycles in the United States using fresh nondonor eggs. Numbers in parentheses are percentages of cycles started that reached each stage. 2002 data from the CDC
Figure 16-3 Some of the advanced fertility treatments available for couples in which the woman has ovarian malfunctions, tubal blockage, or uterine problems. X, abnormal function. AIH, artificial insemination with the husband’s sperm. Donor sperm could be used for each procedure if the husband is infertile or if the woman is unmarried.